Psychological treatment for cognitive impairment support
Official title: Evaluation of a Novel Psychological Intervention Tailored for Patients With Early Cognitive Impairment (PIPCI)
Run by Karolinska Institutet · NCT04356924 · Data updated 2026-11-12
This study is testing a new psychological treatment to help people with mild cognitive issues feel better and improve their daily lives.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 75 Years |
| Sex | All |
| Enrollment | 138 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm, Stockholm County) |
| Status | Recruiting |
| Started | September 7, 2023 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2028 |
| Registry record updated | July 1, 2025 |
| Trial ID | NCT04356924 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals under 75 years old diagnosed with subjective cognitive decline or mild cognitive impairment who experience mild to moderate psychological symptoms.
✕Probably not a fit
Patients with a diagnosis of dementia or severe psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on providing psychological treatment to individuals experiencing cognitive impairment, specifically those with subjective cognitive decline (SCD) and mild cognitive impairment (MCI). The intervention is based on a novel treatment manual that incorporates cognitive behavioral therapy (CBT) principles, adapted to meet the needs of cognitively affected individuals. The approach aims to facilitate behavioral changes aligned with personal values and long-term goals, while addressing associated psychological symptoms such as anxiety and depression. Participants will receive support through reminders and tailored sessions to enhance their daily functioning and quality of life.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the psychological well-being and daily functioning of patients with cognitive impairment.
How similar studies have gone: Other studies have shown promise in using psychological interventions for cognitive impairment, suggesting that this approach could be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Criteria's for inclusion * \< 75 years. * SCD or MCI diagnosis. All cognitive MCI-subtypes are eligible. * Mild to moderate psychological symptoms that are indicated to be related to the patient's CI. The psychological symptoms should affect the patients daily living and behavior, exemplified by avoidance behavior, social anxiety and perceived stigmatization. * Fluency in the Swedish language. * The patients should have access to a mobile telephone to be able to receive reminders via Short Message Service (SMS). * Signed informed consent. * Criteria's for exclusion * Dementia diagnosis and/or occurrence of serious illness and/or injury that requires immediate investigation or treatment of another type, or which is expected to worsen in the coming year (i.e., not including dementia) * Severe psychiatric comorbidity (e.g., high suicide risk), and/or severe psychiatric disorder. This will be assessed in the MINI evaluation and during the clinical cognitive examination). * Anti-depressant medication introduced or alterations in dosage \< 6 months ago (i.e., un-stable dose). * Mini Mental State Examination (MMSE) score \< 26 and/or a Montreal Cognitive Assessment (MoCA) score \< 24. * Stroke or head trauma \< 6 months ago. * Substance abuse
Where it's running
-
Karolinska University Hospital
Stockholm, Stockholm County, Sweden Recruiting
Study contacts
- Study coordinator: Urban Ekman, PhD
- Email: urban.ekman@ki.se
- Phone: +468-517 713 66
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep Better, Live Better: a 12-week coaching program to help adults improve sleep and heart-brain health
This trial tests a 12-week, telephone- and text-based sleep coaching program for adults 25–65 with short sleep and higher cardiometabolic risk to see if it improves sleep and related behaviors.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Digital Mental Health support for Asian Americans
We’re testing online digital tools to help Asian American adults cope with sociocultural stressors, by training clinicians and seeing if outcomes improve for clients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.